Phoenix Molecular Designs
Vancouver, Canada · Founded 2012 · $14.7M raised
- Headquarters
- Vancouver
- Founded
- 2012
- Website
- phoenixmd.ca
- Total Funding
- $14.7M
- Last Round
- $12.0M SeedNov 2019
- Rounds
- 2
About
Phoenix Molecular Designs was founded by Dr. Sandra Dunn in 2012 with a singular vision to transform the way breast cancer is treated. Her work has contributed to the discovery and development of PMD-026, a first-in-class RSK2 inhibitor currently in Phase 2 clinical trials, advancing therapies aimed at improving outcomes for women facing breast cancer.
Summary
Phoenix Molecular Designs is a Biotech company based in Vancouver, Canada, founded in 2012. It has raised $14.7M in total across 2 rounds, most recently a $12.0M Seed round in Nov 2019. Investors include Pallasite Ventures.
Funding History
Nov 2019
Sign up to see all 2 rounds
Venture Round through Seed — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
Specialty pharmaceutical company focused on addressing therapeutic needs in the fields of psychia...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/phoenix-molecular-designs"><img src="https://indexed.vc/api/badge/company/phoenix-molecular-designs" alt="Phoenix Molecular Designs on Indexed.vc" width="260" height="76" /></a>